Roman Kaplan

Title: Roman Kaplan: Innovator in Pharmaceutical Formulations

Introduction

Roman Kaplan is a notable inventor based in Holon, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release formulations. His work focuses on improving the efficacy and delivery of anti-epileptic medications.

Latest Patents

Kaplan holds a patent for a sustained release formulation of carbamazepine. This invention provides a pharmaceutical preparation in tablet form, where the active ingredient is an anti-epileptic medication. The formulation consists of carbamazepine particles coated with a single hydrophobic layer, designed to be in a disintegrating tablet form. This innovative approach enhances the delivery and effectiveness of the medication.

Career Highlights

Roman Kaplan is associated with Taro Pharmaceutical Industries Limited, a company known for its commitment to developing high-quality pharmaceutical products. His work at Taro has allowed him to focus on creating advanced formulations that meet the needs of patients requiring anti-epileptic treatments.

Collaborations

Kaplan has collaborated with talented professionals in his field, including Daniela Licht and Marina Zholkoysky. These collaborations have contributed to the success of his projects and the advancement of pharmaceutical innovations.

Conclusion

Roman Kaplan's contributions to the pharmaceutical industry, particularly through his patent for a sustained release formulation of carbamazepine, highlight his role as an innovator. His work continues to impact the effectiveness of treatments for epilepsy, showcasing the importance of innovation in healthcare.